Document is current
Any future updates will be listed below
-
Authors
Li, Erwei
Wang, Luhong
Wang, Daqing
Chi, Jingyi
Lin, Zeran https://orcid.org/0000-0003-4418-2443
Smith, Gordon I.
Klein, Samuel https://orcid.org/0000-0001-7127-1156
Cohen, Paul https://orcid.org/0000-0002-2786-8585
Rosen, Evan D. https://orcid.org/0000-0003-4603-708X
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 3 November 2023
First Online: 13 December 2023
Competing interests
: E.D.R. receives consulting fees from Novartis. All other authors declare no competing interests.
